For decades, taking low-dose aspirin (81 mg) every day was widely recommended ... Yet 57 percent of people ages 50 to 80 who regularly take low-dose aspirin probably won’t benefit from it ...

Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in the PI3K ...

After endoscopic documentation of ulcer healing, patients received either clopidogrel (75 mg daily) plus placebo or aspirin (80 mg daily) plus esomeprazole (20 mg twice daily). Patients who tested ...

Aspirin did not provide any clinical benefits in a cohort of patients with colorectal cancer who had no history of cardiovascular disease or stroke.

Nearly one in three Americans over the age of 60 — roughly 19 million people — take aspirin daily, according to a 2021 study in Annals of Internal Medicine. Should you be among that group?

or 80-mg Pravachol tablets. The recommended daily dose is 40 mg Pravachol with either 81 mg or 325 mg buffered aspirin. The daily dose of Pravachol is then titrated to achieve desired cholesterol ...

FRIDAY, Jan. 31, 2025 (HealthDay News) -- Adjuvant treatment with 160 mg aspirin daily for three years cuts recurrence rates in patients with colorectal cancer with somatic alterations in the ...

These are the signs to look out for. Need a break? Play the USA TODAY Daily Crossword Puzzle. It's not that aspirin is point-blank no longer recommended. But as medical professionals learn more ...

Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says. Taking 160 milligrams of aspirin a day cuts the risk of cancer ...

Adjuvant treatment with aspirin is associated with a lower risk of recurrence at 3 years in CRC patients with PI3K pathway ...